ABK Biomedical

ABK Biomedical is focused on researching, developing, and commercializing medical device therapies to improve treatment outcomes and the lives of patients with liver tumors. With its multi-disciplinary experience in engineering, material science, oncology, medical science, and more, ABK is equipped to drive the next level of technology for personalized healthcare in oncology. ABK products include Eye90 microspheres, a novel technology with a imageable glass composition for in-procedure visualization, and Easi-Vue embolic microspheres, an imageable bland embolization that allows direct visualization at the target site.

Additional Details

Global Headquarters:

Halifax, Canada